Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Standard view
Full view
of .
Look up keyword
Like this
0Activity
0 of .
Results for:
No results containing your search query
P. 1
UE LifeSciences Launches WeMustTry.com Crowdfunding Campaign for Low-cost, Painless Breast Cancer Screening Services Focused on Developing Countries

UE LifeSciences Launches WeMustTry.com Crowdfunding Campaign for Low-cost, Painless Breast Cancer Screening Services Focused on Developing Countries

Ratings: (0)|Views: 65|Likes:
Published by Crowdsourcing.org

More info:

Published by: Crowdsourcing.org on Oct 24, 2013
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
See more
See less

10/24/2013

 
 PHILADELPHIA, Oct. 22, 2013 /PRNewswire/ --UE LifeSciences Inc. (UELS), medical device maker of innovative breast cancer detection tools, has announced a crowd-funding campaign to help fightbreast cancer. The 'We Must Try' campaign will offer 25,000 women painless and radiation-freebreast examinations at several clinics in India, Mexico, Panama, Brazil and Egypt.(Photo:http://photos.prnewswire.com/prnh/20131022/PH01810-a)(Photo:http://photos.prnewswire.com/prnh/20131022/PH01810-b)"The goal is to identify breast cancers earlier to directly and positively impact treatment outcomesand extend quality life," saidDr. Ari Brooks, Director of the Integrated Breast Center at PennsylvaniaHospital. "We Must Try has this goal at the heart of its campaign.""7 out of 10 breast cancer deaths are now occurring in low-resource countries where mammographyscreening, the only known model for early detection, is virtually impossible to implement at a largescale," saysDr. Mahesh Shetty, Clinical Professor of Radiology, Baylor College of Medicine. "Weneed a paradigm shift, a model that works specifically for low-resource regions," he added.The 'We Must Try' campaign will bring a set of non-invasive and easy-to-use early detection toolsdeveloped by UE LifeSciences to areas where the vast majority of breast cancer cases are reportedat late stages, with poor prognosis. A detailed report at the end of the project will be shared withhealth authorities in several developing countries to help establish a new, sustainable framework for breast cancer detection.UELS'NoTouch BreastScan(NTBS,www.NoTouchBreastScan.com) device is a contact-free breast- imaging toolcleared by the FDA(Feb. 2012) for the detection of breast cancer. UELS is alsodeveloping theIntelligent Breast Exam(iBE,www.iBreastExam.com), a novel hand-held, battery-
Screening camp in Mumbai, India. (PRNewsFoto/UE LifeSciences Inc.)
UE LifeSciences Launches WeMustTry.com Crowdfunding Campaign for...http://www.printthis.clickability.com/pt/cpt?expire=&title=UE+LifeScien...1 of 210/24/2013 3:03 PM

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->